# Cambrex Charles City, Inc. – FDA Inspection, Aug 2, 2013

Source: https://www.keypedia.com/records/fda_inspections/cambrex-charles-city-inc/147242f0-cce7-4513-bca0-cfa211d9eb76
Source feed: FDA_Inspections

> FDA inspection 843001 of Cambrex Charles City, Inc., August 02, 2013. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 843001
- Company Name: Cambrex Charles City, Inc.
- Inspection Date: 2013-08-02
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1266564 - 2025-03-07](https://www.keypedia.com/records/fda_inspections/cambrex-charles-city-inc/bd4a48d6-1e7e-49c5-bf07-f30760432852)
- FDA Inspection 1169072 - 2022-05-02
- [FDA Inspection 1009802 - 2016-12-22](https://www.keypedia.com/records/fda_inspections/cambrex-charles-city-inc/de2f03c8-7b22-46af-bf45-3f3f219687b5)
- FDA Inspection 868083 - 2014-02-27
- FDA Inspection 768805 - 2012-02-28

Company: https://www.keypedia.com/companies/cambrex-charles-city-inc/b14d342b-e5ae-4df6-ad7a-39cd62dfb9c6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
